Amussen Hunsaker Associates LLC Merck & Co., Inc. Transaction History

Amussen Hunsaker Associates LLC

$715 Million
Q3 2024

A detailed history of Amussen Hunsaker Associates LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Amussen Hunsaker Associates LLC holds 8,222 shares of MRK stock, worth $806,167. This represents 0.13% of its overall portfolio holdings.

Number of Shares

8,222

Previous 8,217 0.06%

Holding current value

$806,167

Previous $1.02 Million 8.26%

% of portfolio

0.13%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $555 - $644	5 Added 0.06%	8,222 $933,000
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $742 - $797	6 Added 0.07%	8,217 $1.02 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $20,043 - $23,355	-177 Reduced 2.11%	8,211 $1.08 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $18,833 - $20,495	188 Added 2.29%	8,388 $914,000
Q3 2023 Nov 13, 2023	SELL	$102.95 - $114.33 $6,177 - $6,859	-60 Reduced 0.73%	8,200 $844,000
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $868 - $947	8 Added 0.1%	8,260 $953,000
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $63,616 - $70,983	618 Added 8.1%	8,252 $877,000
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $786 - $1,008	9 Added 0.12%	7,634 $846,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4,226 - $4,748	-50 Reduced 0.65%	7,625 $657,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $751 - $851	9 Added 0.12%	7,675 $700,000
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $26,831 - $30,076	-365 Reduced 4.54%	7,666 $628,000
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $15,251 - $19,103	211 Added 2.7%	8,031 $618,000
Q3 2021 Nov 16, 2021	BUY	$71.68 - $78.83 $2,723 - $2,995	38 Added 0.49%	7,820 $587,000
Q2 2021 Aug 17, 2021	SELL	$70.31 - $77.77 $70 - $77	-1 Reduced 0.01%	7,782 $612,000
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $1,996 - $2,352	-29 Reduced 0.37%	7,783 $599,000
Q4 2020 Feb 17, 2021	BUY	$71.77 - $79.65 $645 - $716	9 Added 0.12%	7,812 $639,000
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $62,056 - $70,341	848 Added 12.19%	7,803 $609,000
Q2 2020 Aug 17, 2020	SELL	$70.42 - $80.13 $51,899 - $59,055	-737 Reduced 9.58%	6,955 $602,000
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $22,746 - $31,527	-359 Reduced 4.46%	7,692 $564,000
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $59,115 - $66,705	762 Added 10.45%	8,051 $733,000
Q2 2019 Aug 20, 2019	BUY	$69.84 - $81.59 $349 - $407	5 Added 0.07%	7,289 $611,000
Q1 2019 May 16, 2019	BUY	$69.58 - $79.36 $89,340 - $101,898	1,284 Added 21.4%	7,284 $606,000
Q4 2018 Feb 19, 2019	SELL	$65.24 - $75.71 $67,131 - $77,905	-1,029 Reduced 14.64%	6,000 $458,000
Q3 2018 Nov 16, 2018	BUY	$57.69 - $67.84 $405,503 - $476,847	7,029 New	7,029 $499,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amussen Hunsaker Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Amussen Hunsaker Associates LLC with notifications on news.

Account

Amussen Hunsaker Associates LLC Merck & Co., Inc. Transaction History